SK10972002A3 - Duálne inhibítory cholesterylesteru a syntéza voskového esteru na liečenie ochorení tukových žliaz - Google Patents

Duálne inhibítory cholesterylesteru a syntéza voskového esteru na liečenie ochorení tukových žliaz Download PDF

Info

Publication number
SK10972002A3
SK10972002A3 SK1097-2002A SK10972002A SK10972002A3 SK 10972002 A3 SK10972002 A3 SK 10972002A3 SK 10972002 A SK10972002 A SK 10972002A SK 10972002 A3 SK10972002 A3 SK 10972002A3
Authority
SK
Slovakia
Prior art keywords
acne
acetyl
triisopropylphenyl
sulfamic acid
ester
Prior art date
Application number
SK1097-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Reynold Homan
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of SK10972002A3 publication Critical patent/SK10972002A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1097-2002A 2000-02-02 2001-01-23 Duálne inhibítory cholesterylesteru a syntéza voskového esteru na liečenie ochorení tukových žliaz SK10972002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17977800P 2000-02-02 2000-02-02
PCT/US2001/002190 WO2001056556A2 (en) 2000-02-02 2001-01-23 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders

Publications (1)

Publication Number Publication Date
SK10972002A3 true SK10972002A3 (sk) 2003-07-01

Family

ID=22657957

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1097-2002A SK10972002A3 (sk) 2000-02-02 2001-01-23 Duálne inhibítory cholesterylesteru a syntéza voskového esteru na liečenie ochorení tukových žliaz

Country Status (34)

Country Link
US (2) US6730703B2 (ru)
EP (1) EP1263421B1 (ru)
JP (1) JP2003531113A (ru)
KR (1) KR20020073574A (ru)
CN (1) CN1398182A (ru)
AP (1) AP2002002612A0 (ru)
AT (1) ATE295724T1 (ru)
AU (1) AU781563B2 (ru)
BG (1) BG107042A (ru)
BR (1) BR0107954A (ru)
CA (1) CA2398219A1 (ru)
CR (1) CR6712A (ru)
DE (1) DE60110897T2 (ru)
DZ (1) DZ3288A1 (ru)
EA (1) EA004255B1 (ru)
EE (1) EE200200429A (ru)
ES (1) ES2239145T3 (ru)
GE (1) GEP20043286B (ru)
HR (1) HRP20020717A2 (ru)
HU (1) HUP0301010A3 (ru)
IL (1) IL150865A0 (ru)
IS (1) IS6478A (ru)
MA (1) MA26872A1 (ru)
MX (1) MXPA02007309A (ru)
NO (1) NO20023659L (ru)
NZ (1) NZ520330A (ru)
OA (1) OA12173A (ru)
PL (1) PL357041A1 (ru)
PT (1) PT1263421E (ru)
SK (1) SK10972002A3 (ru)
UA (1) UA75345C2 (ru)
WO (1) WO2001056556A2 (ru)
YU (1) YU57502A (ru)
ZA (1) ZA200206075B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
ATE409470T1 (de) 2003-10-09 2008-10-15 Warner Lambert Co Pharmazeutische zusammensetzungen mit malonamid- derivaten zur verringerung der talg-produktion
CN101111470A (zh) 2005-02-24 2008-01-23 沃尼尔·朗伯有限责任公司 结晶性酰基CoA胆固醇酰基转移酶抑制剂
FR2904002A1 (fr) * 2006-07-19 2008-01-25 Galderma Res & Dev S N C Snc Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2938342A1 (fr) * 2008-11-13 2010-05-14 Galderma Res & Dev Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
CA2750233A1 (en) 2009-01-28 2010-08-05 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US4751026A (en) 1986-03-24 1988-06-14 Warner-Lambert Company Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase
US4722927A (en) 1986-04-28 1988-02-02 Warner-Lambert Company Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
JPS6323848A (ja) 1986-07-11 1988-02-01 ワ−ナ−−ランバ−ト・コンパニ− Ω−(置換フエニルオキシ)−アルカン酸のアリ−ル−およびアラルキルアミド
US4716175A (en) 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
IE61716B1 (en) 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds
US5015644A (en) 1987-06-02 1991-05-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
DE3861988D1 (en) 1987-07-02 1991-04-18 Warner Lambert Co N-((2,6-disubstituierte)-phenyl)-harnstoff und -carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase.
US5116848A (en) 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
US5030653A (en) 1988-03-30 1991-07-09 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4868210A (en) 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4999373A (en) 1988-03-30 1991-03-12 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4948806A (en) 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4923896A (en) 1989-02-09 1990-05-08 Warner-Lambert Company N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US5155127A (en) 1989-02-09 1992-10-13 Warner-Lambert Company N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US4994465A (en) 1989-02-17 1991-02-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
AU632809B2 (en) 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
AU629376B2 (en) 1989-08-04 1992-10-01 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
WO1991004027A1 (en) 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (ru) 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd
JPH05310678A (ja) 1990-01-22 1993-11-22 Mitsubishi Kasei Corp 1−フェニルアルキル−3−フェニル尿素誘導体
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
ES2125325T3 (es) 1992-01-23 1999-03-01 Pfizer Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
WO1993024458A1 (en) 1992-05-28 1993-12-09 Pfizer Inc. New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
US5565472A (en) 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US5596001A (en) 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
US5494172A (en) * 1994-05-12 1996-02-27 Miller Compressing Company Magnetic pulley assembly
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
ATE248845T1 (de) * 1998-06-25 2003-09-15 Tularik Inc Arylsulfonanilid-phosphate
PE20020453A1 (es) * 2000-09-27 2002-06-06 Merck & Co Inc Derivados del acido benzopirancarboxilico para el tratamiento de la diabetes y los trastornos de lipidos

Also Published As

Publication number Publication date
BG107042A (bg) 2003-04-30
CN1398182A (zh) 2003-02-19
DE60110897T2 (de) 2006-03-23
DZ3288A1 (en) 2001-08-09
HRP20020717A2 (en) 2003-12-31
JP2003531113A (ja) 2003-10-21
HUP0301010A3 (en) 2005-03-29
AU781563B2 (en) 2005-06-02
CA2398219A1 (en) 2001-08-09
US20040161393A1 (en) 2004-08-19
AU2971801A (en) 2001-08-14
ATE295724T1 (de) 2005-06-15
BR0107954A (pt) 2002-10-22
NZ520330A (en) 2004-02-27
IS6478A (is) 2002-07-19
EA200200764A1 (ru) 2002-12-26
US20030060507A1 (en) 2003-03-27
MA26872A1 (fr) 2004-12-20
DE60110897D1 (de) 2005-06-23
WO2001056556A2 (en) 2001-08-09
AP2002002612A0 (en) 2002-09-30
EP1263421A2 (en) 2002-12-11
CR6712A (es) 2004-01-14
OA12173A (en) 2006-05-08
ES2239145T3 (es) 2005-09-16
ZA200206075B (en) 2003-10-30
EE200200429A (et) 2003-12-15
GEP20043286B (en) 2004-07-26
KR20020073574A (ko) 2002-09-27
EA004255B1 (ru) 2004-02-26
UA75345C2 (en) 2006-04-17
NO20023659D0 (no) 2002-08-01
WO2001056556A3 (en) 2002-03-07
IL150865A0 (en) 2003-02-12
YU57502A (sh) 2006-01-16
PT1263421E (pt) 2005-08-31
MXPA02007309A (es) 2002-11-29
HUP0301010A2 (hu) 2003-08-28
EP1263421B1 (en) 2005-05-18
NO20023659L (no) 2002-09-25
US6730703B2 (en) 2004-05-04
PL357041A1 (en) 2004-07-12

Similar Documents

Publication Publication Date Title
EP0098743B1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
US8679552B2 (en) Acne vulgaris treatment regimen
US5688812A (en) Method of inhibiting seborrhea and acne
EP0699439B1 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
US3934028A (en) Acne and psoriasis treatment with retinoic acid analogs
RU2619851C2 (ru) Композиция, включающая дииндолилметан и ретиноид для лечения кожной патологии
US4021573A (en) Psoriasis treatment with retinoic acid analogs
LU84892A1 (fr) Komposition zur reduktion der sebumsekretion
SK10972002A3 (sk) Duálne inhibítory cholesterylesteru a syntéza voskového esteru na liečenie ochorení tukových žliaz
US4035510A (en) Treatment of acne utilizing N-methyldiethanolamine
US5369126A (en) Nonatetraenoic acid derivative for use in treating acne
JPS58103319A (ja) 皮膚塗布用組成物
JPS6360935A (ja) 皮脂抑制用外用剤
JPH0449216A (ja) メラニン抑制剤
KR19990052470A (ko) 면포 용해효과를 갖는 조성물
JP2000143517A (ja) 皮膚外用剤
JP2000143518A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
FC9A Refused patent application